Recombinant Rat IFN-gamma protein (His Tag)
ED50
6-22 ng/mL
Species
Rat
Purity
>95 %, SDS-PAGE
GeneID
25712
Accession
P01581
验证数据展示
Technical Specifications
Purity | >95 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
Immobilized Rat IFN-gamma (His tag) at 1 μg/mL (100 μL/well) can bind Rat IFN-gamma R1 (hFc tag) with a linear range of 6-22 ng/mL. |
Source | HEK293-derived Rat IFN-gamma protein Gln23-Cys156 (Accession# P01581) with a His tag at the C-terminus. |
Predicted Molecular Mass | 18 kDa |
SDS-PAGE | 22-32 kDa, reducing (R) conditions |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
The IFNs were originally discovered as agents that interfere with viral replication. Initially, they were classified by the secreting cell type but are now classified into type I and type II according to receptor specificity and sequence homology. Interferon gamma (Ifng) is a soluble cytokine that is the only member of the type II class of interferons. It is secreted by Th1 cells, cytotoxic T cells and NK cells. The cytokine is associated with antiviral, immunoregulatory and anti-tumor properties and is a potent activator of macrophages. It plays crucial roles in pathogen clearance. Aberrant Ifng expression is associated with a number of autoinflammatory and autoimmune diseases. It has been identified in many studies as a biomarker for pleural tuberculosis (TB). Mutations in this gene are associated with aplastic anemia.
References:
1. Isaacs, A. et al.(1957) The interferon Proc. R. Soc. Lond. B Biol. Sci. 147: 258-267. 2. Gray PW. et al. (1982) Nature. 298 : 859-63. 3. Bullens, D. M. et al.(2001) Int. Immunol. 13: 181-191. 4. Wang Z. et al.(2014) Biosci Biotechnol Biochem.78: 588-92. 5. Chegou NN. et al.(2012)PLoS One.7(6):e38501 6. Torok-Storb B. et al. (Blood) 69:629-33.